Welcome to LookChem.com Sign In|Join Free
  • or
Hypercalcemia of Malignancy Factor (1-37) (Human, Rat) is a peptide hormone derived from parathyroid hormone-related protein (PTHrP) that plays a crucial role in regulating calcium levels in the body. It is known for its ability to induce hypercalcemia, or elevated levels of calcium in the blood, in individuals with certain malignancies. This peptide has been studied for its potential role in promoting bone resorption, increasing calcium excretion, and as a therapeutic target for managing hypercalcemia in cancer patients.

206010-80-2

Post Buying Request

206010-80-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

206010-80-2 Usage

Uses

Used in Pharmaceutical Industry:
Hypercalcemia of Malignancy Factor (1-37) (Human, Rat) is used as a research tool for understanding the mechanisms behind hypercalcemia in cancer patients. It aids in the development of potential therapeutic agents and strategies to manage this condition.
Used in Cancer Research:
Hypercalcemia of Malignancy Factor (1-37) (Human, Rat) is used as a biomarker for studying the role of this peptide in promoting bone resorption and increasing calcium excretion in cancer patients. It helps researchers to identify potential targets for the development of new treatments for hypercalcemia associated with malignancies.
Used in Drug Development:
Hypercalcemia of Malignancy Factor (1-37) (Human, Rat) is used as a target for the development of drugs that can modulate its activity, potentially leading to the management of hypercalcemia in cancer patients. These drugs may work by inhibiting the effects of this peptide or by enhancing the body's natural mechanisms to counteract hypercalcemia.
Used in Diagnostic Applications:
Hypercalcemia of Malignancy Factor (1-37) (Human, Rat) is used as a diagnostic marker to identify patients with hypercalcemia associated with malignancies. Detection of elevated levels of this peptide in blood samples can help in the early diagnosis and monitoring of cancer patients with hypercalcemia.
Further research is needed to fully understand the mechanisms and potential clinical applications of Hypercalcemia of Malignancy Factor (1-37) (Human, Rat) in managing hypercalcemia in cancer patients and its role in bone resorption and calcium excretion.

Check Digit Verification of cas no

The CAS Registry Mumber 206010-80-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,0,1 and 0 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 206010-80:
(8*2)+(7*0)+(6*6)+(5*0)+(4*1)+(3*0)+(2*8)+(1*0)=72
72 % 10 = 2
So 206010-80-2 is a valid CAS Registry Number.

206010-80-2Upstream product

206010-80-2Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 206010-80-2